SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Petmed Express Inc – ‘10-Q’ for 12/31/19 – ‘EX-101.SCH’

On:  Tuesday, 1/28/20, at 12:01pm ET   ·   For:  12/31/19   ·   Accession #:  1437749-20-1273   ·   File #:  0-28827

Previous ‘10-Q’:  ‘10-Q’ on 10/30/19 for 9/30/19   ·   Next:  ‘10-Q’ on 8/3/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 4/15/24 for 12/31/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/28/20  Petmed Express Inc                10-Q       12/31/19   43:2.6M                                   RDG Filings/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    366K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
34: R1          Document And Entity Information                     HTML     47K 
14: R2          Condensed Consolidated Balance Sheets (Current      HTML     94K 
                Period Unaudited)                                                
27: R3          Condensed Consolidated Balance Sheets (Current      HTML     40K 
                Period Unaudited) (Parentheticals)                               
40: R4          Condensed Consolidated Statements of Comprehensive  HTML     82K 
                Income (Unaudited)                                               
33: R5          Condensed Consolidated Statements of Cash Flows     HTML     85K 
                (Unaudited)                                                      
13: R6          Note 1 - Summary of Significant Accounting          HTML     38K 
                Policies                                                         
26: R7          Note 2 - Revenue Recognition                        HTML     81K 
39: R8          Note 3 - Net Income Per Share                       HTML     49K 
35: R9          Note 4 - Stock-based Compensation                   HTML     24K 
20: R10         Note 5 - Fair Value                                 HTML     22K 
17: R11         Note 6 - Commitments and Contingencies              HTML     23K 
29: R12         Note 7 - Changes in Shareholders' Equity and        HTML     71K 
                Comprehensive Income                                             
43: R13         Note 8 - Income Taxes                               HTML     22K 
19: R14         Note 9 - Subsequent Events                          HTML     19K 
16: R15         Significant Accounting Policies (Policies)          HTML     41K 
28: R16         Note 2 - Revenue Recognition (Tables)               HTML     74K 
42: R17         Note 3 - Net Income Per Share (Tables)              HTML     45K 
21: R18         Note 7 - Changes in Shareholders' Equity and        HTML     67K 
                Comprehensive Income (Tables)                                    
15: R19         Note 1 - Summary of Significant Accounting          HTML     19K 
                Policies (Details Textual)                                       
32: R20         Note 2 - Revenue Recognition (Details Textual)      HTML     17K 
37: R21         Note 2 - Revenue Recognition - Disaggregation of    HTML     35K 
                Revenue by Type (Details)                                        
25: R22         Note 3 - Net Income Per Share (Details Textual)     HTML     16K 
12: R23         Note 3 - Net Income Per Share - Basic and Diluted   HTML     47K 
                Net Income Per Share (Details)                                   
31: R24         Note 4 - Stock-based Compensation (Details          HTML     39K 
                Textual)                                                         
36: R25         Note 5 - Fair Value (Details Textual)               HTML     17K 
24: R26         Note 6 - Commitments and Contingencies (Details     HTML     16K 
                Textual)                                                         
11: R27         Note 7 - Changes in Shareholders' Equity and        HTML     23K 
                Comprehensive Income (Details Textual)                           
30: R28         Note 6 - Changes in Shareholders' Equity and        HTML     45K 
                Comprehensive Income: - Schedule of Changes in                   
                Shareholders' Equity (Details)                                   
38: R29         Note 8 - Income Taxes (Details Textual)             HTML     26K 
41: R30         Note 9 - Subsequent Events (Details Textual)        HTML     27K 
18: XML         IDEA XML File -- Filing Summary                      XML     73K 
23: EXCEL       IDEA Workbook of Financial Reports                  XLSX     32K 
 5: EX-101.INS  XBRL Instance -- pets-20191231                       XML    699K 
 7: EX-101.CAL  XBRL Calculations -- pets-20191231_cal               XML     79K 
 8: EX-101.DEF  XBRL Definitions -- pets-20191231_def                XML    469K 
 9: EX-101.LAB  XBRL Labels -- pets-20191231_lab                     XML    404K 
10: EX-101.PRE  XBRL Presentations -- pets-20191231_pre              XML    490K 
 6: EX-101.SCH  XBRL Schema -- pets-20191231                         XSD     78K 
22: ZIP         XBRL Zipped Folder -- 0001437749-20-001273-xbrl      Zip     62K

‘EX-101.SCH’   —   XBRL Schema — pets-20191231

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Generated by ThunderDome XBRL - 09:02PM UTC 2020-01-27 -->
<xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:pets="http://www.1800petmeds.com/20191231" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.1800petmeds.com/20191231">
<xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd"/>
<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.1800petmeds.com/20191231/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 000 - Document - Document And Entity Information </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-condensed-consolidated-balance-sheets-current-period-unaudited" roleURI="http://www.1800petmeds.com/20191231/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" roleURI="http://www.1800petmeds.com/20191231/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-condensed-consolidated-statements-of-comprehensive-income-unaudited" roleURI="http://www.1800petmeds.com/20191231/role/statement-condensed-consolidated-statements-of-comprehensive-income-unaudited">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-condensed-consolidated-statements-of-cash-flows-unaudited" roleURI="http://www.1800petmeds.com/20191231/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-1-summary-of-significant-accounting-policies" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-1-summary-of-significant-accounting-policies">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 005 - Disclosure - Note 1 - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-2-revenue-recognition" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-2-revenue-recognition">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 006 - Disclosure - Note 2 - Revenue Recognition </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-net-income-per-share" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-3-net-income-per-share">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 007 - Disclosure - Note 3 - Net Income Per Share </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-stockbased-compensation" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-4-stockbased-compensation">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 008 - Disclosure - Note 4 - Stock-based Compensation </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-5-fair-value" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-5-fair-value">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 009 - Disclosure - Note 5 - Fair Value </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-commitments-and-contingencies" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-6-commitments-and-contingencies">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 010 - Disclosure - Note 6 - Commitments and Contingencies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-changes-in-shareholders-equity-and-comprehensive-income" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-7-changes-in-shareholders-equity-and-comprehensive-income">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 011 - Disclosure - Note 7 - Changes in Shareholders' Equity and Comprehensive Income: </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-8-income-taxes" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-8-income-taxes">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 012 - Disclosure - Note 8 - Income Taxes </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-9-subsequent-events" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-9-subsequent-events">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 013 - Disclosure - Note 9 - Subsequent Events </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-significant-accounting-policies-policies" roleURI="http://www.1800petmeds.com/20191231/role/statement-significant-accounting-policies-policies">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 014 - Disclosure - Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-2-revenue-recognition-tables" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-2-revenue-recognition-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 015 - Disclosure - Note 2 - Revenue Recognition (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-net-income-per-share-tables" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-3-net-income-per-share-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 016 - Disclosure - Note 3 - Net Income Per Share (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-changes-in-shareholders-equity-and-comprehensive-income-tables" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-7-changes-in-shareholders-equity-and-comprehensive-income-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 017 - Disclosure - Note 7 - Changes in Shareholders' Equity and Comprehensive Income: (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-1-summary-of-significant-accounting-policies-details-textual" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-1-summary-of-significant-accounting-policies-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 018 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-2-revenue-recognition-details-textual" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-2-revenue-recognition-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 019 - Disclosure - Note 2 - Revenue Recognition (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-2-revenue-recognition-disaggregation-of-revenue-by-type-details" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-2-revenue-recognition-disaggregation-of-revenue-by-type-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 020 - Disclosure - Note 2 - Revenue Recognition - Disaggregation of Revenue by Type (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-net-income-per-share-details-textual" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-3-net-income-per-share-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 021 - Disclosure - Note 3 - Net Income Per Share (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-net-income-per-share-basic-and-diluted-net-income-per-share-details" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-3-net-income-per-share-basic-and-diluted-net-income-per-share-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 022 - Disclosure - Note 3 - Net Income Per Share - Basic and Diluted Net Income Per Share (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-stockbased-compensation-details-textual" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-4-stockbased-compensation-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 023 - Disclosure - Note 4 - Stock-based Compensation (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-5-fair-value-details-textual" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-5-fair-value-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 024 - Disclosure - Note 5 - Fair Value (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-commitments-and-contingencies-details-textual" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-6-commitments-and-contingencies-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 025 - Disclosure - Note 6 - Commitments and Contingencies (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-changes-in-shareholders-equity-and-comprehensive-income-details-textual" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-7-changes-in-shareholders-equity-and-comprehensive-income-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 026 - Disclosure - Note 7 - Changes in Shareholders' Equity and Comprehensive Income: (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-changes-in-shareholders-equity-and-comprehensive-income-schedule-of-changes-in-shareholders-equity-details" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-6-changes-in-shareholders-equity-and-comprehensive-income-schedule-of-changes-in-shareholders-equity-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 027 - Disclosure - Note 6 - Changes in Shareholders' Equity and Comprehensive Income: - Schedule of Changes in Shareholders' Equity (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-8-income-taxes-details-textual" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-8-income-taxes-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 028 - Disclosure - Note 8 - Income Taxes (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-9-subsequent-events-details-textual" roleURI="http://www.1800petmeds.com/20191231/role/statement-note-9-subsequent-events-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 029 - Disclosure - Note 9 - Subsequent Events (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element id="pets_AccruedExpensesAndOtherCurrentLiabilities" name="AccruedExpensesAndOtherCurrentLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="pets_AccruedExpensesAndOtherCurrentLiabilitiesMember" name="AccruedExpensesAndOtherCurrentLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="pets_BasisOfPresentationAndConsolidationPolicyTextBlock" name="BasisOfPresentationAndConsolidationPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_ContactCenterMember" name="ContactCenterMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="pets_CreditCardSalesCashSettlementPeriod" name="CreditCardSalesCashSettlementPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_EmployeeAndDirectorPlansMember" name="EmployeeAndDirectorPlansMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_EmployeeEquityCompensationRestrictedStockPlan2016Member" name="EmployeeEquityCompensationRestrictedStockPlan2016Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_EmployeeEquityCompensationRestrictedStockPlanTheEmployeePlanMember" name="EmployeeEquityCompensationRestrictedStockPlanTheEmployeePlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_InternetMember" name="InternetMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_NewOrderMember" name="NewOrderMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_NoteToFinancialStatementDetailsTextual" name="NoteToFinancialStatementDetailsTextual" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_NotesToFinancialStatements" name="NotesToFinancialStatements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" name="OutsideDirectorEquityCompensationRestrictedStockPlan2015DirectorPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_ReorderMember" name="ReorderMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="pets_RevenueFromContractWithCustomerPercentage" name="RevenueFromContractWithCustomerPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="pets_RevenueFromContractWithCustomerVariance" name="RevenueFromContractWithCustomerVariance" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="pets_RevenueFromContractWithCustomerVariancePercentage" name="RevenueFromContractWithCustomerVariancePercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="pets_TransferOfPropertyAndEquipmentToCurrentAssets" name="TransferOfPropertyAndEquipmentToCurrentAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_TwoThousandAndSixOutsideDirectorEquityCompensationRestrictedStockPlanTheDirectorPlanMember" name="TwoThousandAndSixOutsideDirectorEquityCompensationRestrictedStockPlanTheDirectorPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_statement-statement-note-2-revenue-recognition-disaggregation-of-revenue-by-type-details" name="statement-statement-note-2-revenue-recognition-disaggregation-of-revenue-by-type-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_statement-statement-note-2-revenue-recognition-tables" name="statement-statement-note-2-revenue-recognition-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_statement-statement-note-3-net-income-per-share-basic-and-diluted-net-income-per-share-details" name="statement-statement-note-3-net-income-per-share-basic-and-diluted-net-income-per-share-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_statement-statement-note-3-net-income-per-share-tables" name="statement-statement-note-3-net-income-per-share-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_statement-statement-note-6-changes-in-shareholders-equity-and-comprehensive-income-schedule-of-changes-in-shareholders-equity-details" name="statement-statement-note-6-changes-in-shareholders-equity-and-comprehensive-income-schedule-of-changes-in-shareholders-equity-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_statement-statement-note-7-changes-in-shareholders-equity-and-comprehensive-income-tables" name="statement-statement-note-7-changes-in-shareholders-equity-and-comprehensive-income-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="pets_statement-statement-significant-accounting-policies-policies" name="statement-statement-significant-accounting-policies-policies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>

↑Top
Filing Submission 0001437749-20-001273   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 2:48:07.1pm ET